Registration - Consultant

Rethink Breast Cancer / Derrick Araneda, Consultant

Registration Information

Client name: Rethink Breast Cancer
Lobbyist name: Derrick Araneda, Consultant
Initial registration start date: 2024-04-08
Registration status: Active
Registration Number: 940838-377742

Associated Communications

Total Number of Communication Reports: 5

Monthly communication reports in the last 6 months: 5

Version 1 of 1 (2024-04-08 to present)

Lobbying Information

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Health	Patient access to breakthrough cancer treatment continues to be met with consistent delays in Canada, especially compared to the US and Europe. Rethink Breast Cancer would like to meet with elected officials and policy makers to discuss opportunities to speed up access for cancer patients and improve overall coverage.	Policies or Program

Communication Techniques

Written communication
Oral communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Health Canada (HC)
House of Commons

Government institutions added through a monthly communication report

Indigenous Services Canada (ISC)

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
50 Carroll St
Toronto, ON M4M 3G3
Canada

Telephone number: 416-220-0700

Client representative

MJ DeCoteau, Founder & Executive Director

Parent Company Information

Rethink Breast Cancer is not a subsidiary of any other parent companies.

Coalition Members Information

Rethink Breast Cancer is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Rethink Breast Cancer are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Rethink Breast Cancer does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Derrick Araneda | No public offices held

Business address:
77 Bloor St W Suite 600
Toronto, ON M5S 2B4
Canada

Telephone number: 416-930-2452

Consultant Firm and Address

Firm: S&A Strategies

Address:
77 Bloor St. W, Suite 600
Toronto, ON M5S 1M2
Canada

Telephone number: 416-606-9750

Rethink Breast Cancer/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Rethink Breast Cancer/	2024-04-08	current

Rethink Breast Cancer

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Derrick Araneda, S&A Strategies (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-5 of 5

Rethink Breast Cancer
Consultant: Derrick Araneda

Designated Public Office Holders who participated in the communication:
- Shelby Kramp-Neuman, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-05-09
Posted date: 2024-05-16
Communication number: 377742-604841 View associated registration
Rethink Breast Cancer
Consultant: Derrick Araneda

Designated Public Office Holders who participated in the communication:
- Yvonne Jones, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-05-09
Posted date: 2024-05-16
Communication number: 377742-604840 View associated registration
Rethink Breast Cancer
Consultant: Derrick Araneda

Designated Public Office Holders who participated in the communication:
- Pam Damoff, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-05-09
Posted date: 2024-05-16
Communication number: 377742-604838 View associated registration
Rethink Breast Cancer
Consultant: Derrick Araneda

Designated Public Office Holders who participated in the communication:
- Michelle Mujoomdar , Manager Policy | PHARMACY POLICY DEVELOPMENT DIVISION | Indigenous Services Canada (ISC)
- Daniel McLean, Manager | PHARMACY POLICY DEVELOPMENT DIVISION | Indigenous Services Canada (ISC)
- Karen Fortin, Director | Pharmacy Policy Division, Non-Insured Health Benefits | Indigenous Services Canada (ISC)
Subject Matter of the communication: Health
Communication date: 2024-05-08
Posted date: 2024-05-16
Communication number: 377742-604837 View associated registration
Rethink Breast Cancer
Consultant: Derrick Araneda

Designated Public Office Holders who participated in the communication:
- Dan Albas, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-05-08
Posted date: 2024-05-16
Communication number: 377742-604836 View associated registration

Derrick Araneda, S&A Strategies (Consultant)

Learn more...

Results below are sorted by posted date, beginning with the most recent.

Results 1-5 of 5

Rethink Breast Cancer
Consultant: Derrick Araneda

Designated Public Office Holders who participated in the communication:
- Shelby Kramp-Neuman, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-05-09
Posted date: 2024-05-16
Communication number: 377742-604841 View associated registration
Rethink Breast Cancer
Consultant: Derrick Araneda

Designated Public Office Holders who participated in the communication:
- Yvonne Jones, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-05-09
Posted date: 2024-05-16
Communication number: 377742-604840 View associated registration
Rethink Breast Cancer
Consultant: Derrick Araneda

Designated Public Office Holders who participated in the communication:
- Pam Damoff, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-05-09
Posted date: 2024-05-16
Communication number: 377742-604838 View associated registration
Rethink Breast Cancer
Consultant: Derrick Araneda

Designated Public Office Holders who participated in the communication:
- Michelle Mujoomdar , Manager Policy | PHARMACY POLICY DEVELOPMENT DIVISION | Indigenous Services Canada (ISC)
- Daniel McLean, Manager | PHARMACY POLICY DEVELOPMENT DIVISION | Indigenous Services Canada (ISC)
- Karen Fortin, Director | Pharmacy Policy Division, Non-Insured Health Benefits | Indigenous Services Canada (ISC)
Subject Matter of the communication: Health
Communication date: 2024-05-08
Posted date: 2024-05-16
Communication number: 377742-604837 View associated registration
Rethink Breast Cancer
Consultant: Derrick Araneda

Designated Public Office Holders who participated in the communication:
- Dan Albas, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-05-08
Posted date: 2024-05-16
Communication number: 377742-604836 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Rethink Breast Cancer / Derrick Araneda, Consultant

Registration Information

Associated Communications

Version 1 of 1 (2024-04-08 to present)

Version 1 of 1 (2024-04-08 to present)

Subject Matter Details

Communication Techniques

Government Institutions

Government institutions added through a monthly communication report

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address